The consequences of extended newborn screening programmes: do we know who needs treatment?
The development of an evidence base for newborn screening is especially difficult because of the rarity of disorders now detectable. One consequence of expanded newborn screening is that physicians are being called upon to manage asymptomatic babies with persistent biochemical disturbances that indicate likely enzyme deficiencies. Some of these may be very mild. There is not always agreement as to who should be treated. Particular problems are seen with disorders that were previously thought very rare but are now found frequently by newborn screening. Some of these disorders appear benign or nearly so, and in the present state of knowledge should clearly not be included in routine newborn screening panels.
Wilcken
B
B
Biochemical Genetics and Newborn Screening, The Children’s Hospital at Westmead, Westmead, NSW, Australia. bridgetw@chw.edu.au
D019317:Evidence-Based Medicine; D006801:Humans; D007231:Infant, Newborn; D008661:Metabolism, Inborn Errors / Q000175:diagnosis* / Q000628:therapy*; D015997:Neonatal Screening / Q000379:methods*; D018579:Patient Selection; D011237:Predictive Value of Tests; D011379:Prognosis; D019564:Unnecessary Procedures